Skip to main content
. 2007 May 29;9(3):R33. doi: 10.1186/bcr1681

Table 4.

Univariate and multivariate Cox analyses in the Stiftung Tumorbank Basel data set (n = 317)

Factor Univariate metastasis-free survival Multivariate metastasis-free survival

Hazard ratio (95% confidence interval) P value Hazard ratio (95% confidence interval) P value
E2F1 (>p30 versus ≤ p30) 4.27 (1.83–9.96) 0.001 2.95 (1.10–7.93) 0.032
Grade (3 versus 1 + 2) 2.03 (1.17–3.51) 0.011 1.56 (0.77–3.14) 0.213
Estrogen receptor status (positive versus negative) 0.64 (0.37–1.12) 0.120 1.21 (0.56–2.61) 0.625
ERBB2 status (positive versus negative) 1.69 (0.98–2.92) 0.058 1.41 (0.70–2.81) 0.335
pN (>3 nodes versus ≤ 3 nodes) 3.14 (1.76–5.61) <0.001 2.36 (1.14–4.88) 0.021
Size (>2 cm versus ≤ 2 cm) 1.95 (1.05–3.62) 0.036 1.19 (0.58–2.43) 0.641
Age (≤ 40 years versus >40 years) 0.30 (0.15–0.59) 0.001 0.59 (0.24–1.43) 0.246
Chemotherapy 2.65 (1.54–4.55) <0.001 1.27 (0.45–3.59) 0.654
Hormone therapy 0.50 (0.28–0.88) 0.017 0.76 (0.27–2.17) 0.605
70-gene signature (poor versus good prognosis) Not available Not available Not available Not available
HHS Vulnerability Disclosure